Summary
Machine-generated summaryThis Czech public procurement covers recurring deliveries of medicinal products containing the active substance alemtuzumab, an immunosuppressant. The products must meet the requirements of the State Institute for Drug Control (SUKL). The procedure is structured as a joint purchase for 2026, with repeated supply over the contract term. No specific quantities, lots or delivery locations are described in the description provided.
Description
Official source
Source: TED - Tenders Electronic Daily (Publications Office of the EU)
Always verify details on the official notice.
Last verified against TED - Tenders Electronic Daily (Publications Office of the EU) 7 hours ago
More from this buyer
Full buyer profile2 open tenders right now
- Czech Republic - Other therapeutic products - Products containing zolbetuximab 2026 - joint purchase 27 days left
This buyer has no award history in this sector yet. Usual winners, Medical equipment & pharmaceuticals - Czechia
| Company | Wins | Total awarded | Last win |
|---|---|---|---|
| PHOENIX lékárenský velkoobchod, s.r.o. | 220 | €212.1M | Sep 2026 |
| Alliance Healthcare s.r.o. | 207 | €152.1M | Sep 2026 |
| PROMEDICA PRAHA GROUP, a.s. | 143 | €51.1M | Sep 2026 |
| PHARMOS, a.s. | 111 | €18.7M | Sep 2026 |
| ROCHE s.r.o. | 45 | €101.9M | Aug 2026 |
Based on 2953 awards with a linked company profile over the last 2 years.
Similar tenders
3
days left
€290,468
est. value
3
days left
€674,542
est. value
3
days left
€5,736,062
est. value
3
days left
€1,254,163
est. value
Market context
- Avg. open tender · Medical equipment & pharmaceuticals
- €10,113,906
- Buyer track record on Aperlena
- 2 notices tracked · 0 awarded
Never miss a tender like this
177 new notices in Medical equipment & pharmaceuticals in Czechia in the last 7 days. Get an email when new ones appear. Free.
Set up my alert